Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
03/09/2026 24:45
BRIEF-Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co Sept 3 (Reuters) -
GENETIC SIGNATURES - REQUESTED BCAL DIAGNOSTICS TO CLARIFY DETAILS OF ITS SHAREHOLDINGS AND ASSOCIATES IN GSS
Further company coverage: BDX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genetic Signatures
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Australia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise
Brief: Genetic Signatures Receives Request From BCAL Diagnostics To Call General Meeting Of Shareholders
Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
Brief: Genetic Signatures Announces Board Changes